Testing effectiveness (Phase 2)Ended earlyNCT04145037
What this trial is testing
Lentiviral Vector Gene Therapy - The Guard1 Trial of AVR-RD-02 for Subjects With Type 1 Gaucher Disease
Who this might be right for
Gaucher Disease
AVROBIO 8
Showing 20 of 0 results